Electrosurgical Devices and Surgical Robotics in 2025

The global electrosurgical devices market is undergoing a profound transformation, driven by innovation in surgical techniques and the growing adoption of robotic surgery. The increasing integration of electrosurgical tools into robotic platforms is reshaping the competitive landscape and enhancing the precision of soft tissue surgeries. As the demand for less invasive surgeries rises, electrosurgical devices play a crucial role in this shift, providing surgeons with advanced tools for tissue cutting, coagulation, and ablation.

This article delves into the current state of the electrosurgical devices market, focusing on key industry trends, major players, and emerging technologies that are driving growth in 2025. It also explores how the landscape is shifting, with companies like Medtronic, Johnson & Johnson MedTech, and Intuitive Surgical leading the charge in robotic-assisted surgeries.

Overview of the Electrosurgical Devices Market in 2025

Electrosurgical devices, which have long been integral to operating rooms, have evolved significantly since their early 20th-century inception. Initially used for tissue cutting and coagulation, these devices have now become essential across various surgical specialties, thanks to technological advancements that enhance precision and reduce recovery times.

In recent years, the growth of robotic surgery has elevated the role of electrosurgical devices. This is particularly evident in platforms like Intuitive Surgical’s da Vinci systems, where integrated energy tools are used to optimize outcomes in soft tissue surgeries. As robotic systems continue to improve and expand, the role of electrosurgical devices in these procedures is more critical than ever.

The shift from handheld energy devices to fully integrated robotic platforms is transforming both the device market and the surgical landscape. This evolution presents new opportunities and challenges for companies, as they must adapt their technologies to work seamlessly within robotic ecosystems.

The Numbers Behind Electrosurgical Devices Market Growth

According to LSI’s latest analysis, the global electrosurgical devices market is projected to grow significantly, reaching $14.7 billion by 2029, up from an estimated $10.2 billion in 2024. This growth represents a compounded annual growth rate (CAGR) of 7.6%, driven by the increasing adoption of robotic surgery and the growing volume of soft tissue surgeries worldwide.

LSI’s Global Surgical Procedure Volumes database projects that the total number of soft tissue procedures will rise from 151.7 million in 2024 to 174.9 million by 2029, reflecting a CAGR of 3.0%. This increase in surgical procedures directly fuels demand for electrosurgical devices, particularly in minimally invasive surgeries, where precision and efficiency are paramount.

Medtronic and J&J: Competing in the Robotic Surgery Space

Medtronic and Johnson & Johnson are investing heavily in robotic surgery platforms to compete with Intuitive Surgical, the market leader. Medtronic’s Hugo™ system, a multi-arm robotic platform, is already commercially available outside the U.S., and the company has integrated its Valleylab™ energy platform into this system, offering a complete robotic solution. As Medtronic continues to gather clinical data, it is positioning its robotic platform to rival Intuitive’s dominance.

Similarly, J&J’s OTTAVA™ robotic platform, although still in development, benefits from the company’s established expertise in surgical energy. With its vast portfolio of surgical tools, particularly through its Ethicon division, J&J is well-positioned to integrate electrosurgical devices into its robotic platform once it becomes commercially available.

Both Medtronic and J&J are striving to own the entire surgical workflow, from robotics to energy tools, in a bid to gain control over how surgeries are performed in the future. This competition is setting the stage for a significant shift in the electrosurgical devices market, with companies now focused on creating fully integrated solutions rather than standalone instruments.

Intuitive Surgical’s Dominance in the Electrosurgical Devices Market

Intuitive Surgical, the maker of the da Vinci Surgical System, has emerged as the dominant player in the electrosurgical devices market, particularly in the field of robotic surgery. In 2024, Intuitive captured an estimated 25% of the global electrosurgical devices market, making it the second-largest player, up from 16% in 2020. The company’s ability to integrate its proprietary energy tools, such as the Vessel Sealer Extend, with its da Vinci robotic systems has been a key factor in its success.

As Intuitive continues to lead in the soft tissue robotics space, it is likely to maintain its market share and even expand further, especially as the adoption of robotic surgery grows worldwide. The company’s focus on refining its robotic platforms and ensuring that its energy tools are seamlessly integrated into these systems positions it for continued success in the years ahead.

Innovation in the Electrosurgical Devices Market: Emerging Players

Despite the dominance of established players like Medtronic, J&J, and Intuitive, innovation continues to shape the future of electrosurgical devices. Several emerging companies are developing cutting-edge technologies designed to enhance the capabilities of robotic surgery platforms and improve surgical outcomes. Some of the most notable innovators in this space include:

• US Medical Innovations: Known for its Canady Helios Cold Plasma™ technology, this company is developing a non-thermal cold atmospheric plasma that targets cancer cells and disrupts cellular homeostasis, offering a potential game-changer in oncology surgery.
• Creo Medical: The company’s CROMA™ Advanced Energy Platform uses proprietary Kamaptive™ technology, integrating bipolar radiofrequency and high-frequency microwave energy for precise tissue dissection and hemostasis.

These companies are pushing the boundaries of what’s possible in the electrosurgical devices market, developing tools that enhance the precision, efficiency, and safety of robotic surgeries.

What’s Next for the Electrosurgical Devices Market?

The future of electrosurgical devices is inextricably tied to the continued growth and adoption of robotic surgery. As robotic systems become more advanced and widely used, the demand for integrated energy tools will rise. For device manufacturers, this means that success will depend on their ability to create tools that seamlessly integrate with robotic platforms and deliver superior outcomes for patients.

Medtronic and J&J’s investments in robotic surgery signal a race toward creating the most advanced surgical ecosystems, where electrosurgical tools are essential components. As more robotic platforms enter the market, electrosurgical device manufacturers will need to adapt their products to work within these systems to remain competitive.

Dig Deeper into the Electrosurgical Devices Market with Compass

For those looking to stay ahead in the evolving electrosurgical devices market, LSI’s Compass offers valuable insights. Compass provides detailed market sizing, competitive intelligence, and data on emerging players in the robotic surgery space and the electrosurgical devices market. It’s the ideal tool for medtech executives and investors who want to stay ahead of market trends and identify new opportunities for growth.